Concepedia

Michael D. Miller

MD

Statistics

Publications

209

Citations

18.9K

H-Index

74

Active since

1978

Affiliations

Gilead Sciences (United States)(Current)

United States Military Academy

Merck & Co., Inc., Rahway, NJ, USA (United States)

Michael D. Miller is an author at Gilead Sciences (United States) specializing in molecular virology, antiviral therapy, and virology.

Publications per year

1978–2019

209

Publications

209

Inhibitors of Strand Transfer That Prevent Integration and Inhibit HIV-1 Replication in Cells

Daria J. Hazuda, Peter J. Felock, Marc Witmer et al. · Science · 2000 · 1.1K citations

, , +16

Raltegravir with Optimized Background Therapy for Resistant HIV-1 Infection

Roy T. Steigbigel, David A. Cooper, Princy Kumar et al. · New England Journal of Medicine · 2008 · 686 citations · Full text

, , +17

Safety and efficacy of raltegravir-based versus efavirenz-based combination therapy in treatment-naive patients with HIV-1 infection: a multicentre, double-blind randomised controlled trial

Jeffrey L. Lennox, Edwin DeJesus, Adriano Lazzarin et al. · The Lancet · 2009 · 620 citations

, , +16

A map of human genome variation from population-scale sequencing

Richard Durbin, David L. Altshuler, Gonçalo R. Abecasis et al. · Research at the University of Copenhagen (University of Copenhagen) · 2010 · 542 citations · Full text

, , +17

Subgroup and Resistance Analyses of Raltegravir for Resistant HIV-1 Infection

David A. Cooper, Roy T. Steigbigel, José M. Gatell et al. · New England Journal of Medicine · 2008 · 507 citations · Full text

, , +14

1–5 of 209